Artwork

Content provided by Synthego. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Synthego or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology

26:06
 
Share
 

Manage episode 398454707 series 2430750
Content provided by Synthego. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Synthego or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, oNKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode, they discussed what they do at oNKo-innate, their career transitions from leaving academics to entering the biotech industry, and how CRISPR is impacting cancer-immunotherapy development. They also discussed overcoming common obstacles faced when developing cytokine therapies and future outlooks on clinical trials using these kinds of therapies.

Reach out and connect with both Imran and Junyun on social media platforms:

Imran House, Ph.D.

LinkedIn

X: @ImranHouse

Junyun Lai, Ph.D.

LinkedIn

X: @JunyunLai

  continue reading

44 episodes

Artwork
iconShare
 
Manage episode 398454707 series 2430750
Content provided by Synthego. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Synthego or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, oNKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode, they discussed what they do at oNKo-innate, their career transitions from leaving academics to entering the biotech industry, and how CRISPR is impacting cancer-immunotherapy development. They also discussed overcoming common obstacles faced when developing cytokine therapies and future outlooks on clinical trials using these kinds of therapies.

Reach out and connect with both Imran and Junyun on social media platforms:

Imran House, Ph.D.

LinkedIn

X: @ImranHouse

Junyun Lai, Ph.D.

LinkedIn

X: @JunyunLai

  continue reading

44 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide